45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
17,427
Insurances with rates
9
CPT / HCPCS codes
8,943
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 573101123 | DAUNORUBICIN 20 MG INJ | $985,570 | $251,025 | $492,785 | $492,785 | 3 |
| 573101123 | DAUNORUBICIN 20 MG INJ | $985,570 | $251,025 | $275,959 | $847,590 | 14 |
| 573107113 | GIVOSIRAN 189MG SUBCUTN | $313,164 | $79,763 | $156,582 | $156,582 | 3 |
| 573107113 | GIVOSIRAN 189MG SUBCUTN | $313,164 | $79,763 | $87,686 | $269,321 | 14 |
| 573108196 | TREMELIMUMAB-ACTL 300MG INJ | $292,323 | $74,455 | $146,162 | $146,162 | 3 |
| 573108196 | TREMELIMUMAB-ACTL 300MG INJ | $292,323 | $74,455 | $81,851 | $251,398 | 14 |
| 550021173 | MACI CELL PRODUCT 1 MEMBR 593957 | $224,684 | $57,227 | $56,171 | $56,171 | 3 |
| 550021173 | MACI CELL PRODUCT 1 MEMBR 593957 | $224,684 | $57,227 | $56,171 | $193,228 | 14 |
| 573104448 | USTEKINUMAB SUBCUTANIOUS 90MG | $204,603 | $52,112 | $102,302 | $102,302 | 3 |
| 573104448 | USTEKINUMAB SUBCUTANIOUS 90MG | $204,603 | $52,112 | $57,289 | $175,959 | 14 |
| 573105117 | VIEKIRA XR (200/33.33) TAB | $204,090 | $51,982 | — | — | 0 |
| 573105117 | VIEKIRA XR (200/33.33) TAB | $204,090 | $51,982 | $47.67 | $175,517 | 11 |
| 573108239 | RAVULIZUMAB-CWVZ 1100MG | $172,553 | $43,949 | $86,276 | $86,276 | 3 |
| 573108239 | RAVULIZUMAB-CWVZ 1100MG | $172,553 | $43,949 | $48,315 | $148,395 | 14 |
| 573108255 | OCRELIZUMAB 300MG/10ML INJ VIAL | $144,871 | $36,899 | $72,436 | $72,436 | 3 |
| 573108255 | OCRELIZUMAB 300MG/10ML INJ VIAL | $144,871 | $36,899 | $40,564 | $124,589 | 14 |
| 573105116 | VIEKIRA 28 DAY DOSE PACK | $135,090 | $34,407 | — | — | 0 |
| 573105116 | VIEKIRA 28 DAY DOSE PACK | $135,090 | $34,407 | $47.67 | $116,177 | 11 |
| 550025148 | VALVE HEART SAPIEN3 26MM471004 | $130,000 | $33,111 | $32,500 | $32,500 | 3 |
| 550025148 | VALVE HEART SAPIEN3 26MM471004 | $130,000 | $33,111 | $32,500 | $111,800 | 14 |
| 550024741 | VALVE AORTIC 29 535821 | $120,000 | $30,564 | $30,000 | $30,000 | 3 |
| 550024741 | VALVE AORTIC 29 535821 | $120,000 | $30,564 | $30,000 | $103,200 | 14 |
| 573104447 | USTEKINUMAB SUBCUTANIOUS 45MG | $102,302 | $26,056 | $51,151 | $51,151 | 3 |
| 573104447 | USTEKINUMAB SUBCUTANIOUS 45MG | $102,302 | $26,056 | $28,644 | $87,979 | 14 |
| 550025015 | IMPELLA CATH 5.0 383664 | $100,000 | $25,470 | $25,000 | $25,000 | 3 |
| 550025015 | IMPELLA CATH 5.0 383664 | $100,000 | $25,470 | $25,000 | $86,000 | 14 |
| 573108164 | NIVOLUMAB/RELATIMAB-RMBW 240/80 | $97,862 | $24,925 | $48,931 | $48,931 | 3 |
| 573108164 | NIVOLUMAB/RELATIMAB-RMBW 240/80 | $97,862 | $24,925 | $27,401 | $84,161 | 14 |
| 573108175 | PERTUZ1200/TRASTUZ600 INJ VIAL | $96,179 | $24,497 | $48,089 | $48,089 | 3 |
| 573108175 | PERTUZ1200/TRASTUZ600 INJ VIAL | $96,179 | $24,497 | $26,930 | $82,714 | 14 |
| 550019099 | VALVE HRT SAPIEN23MM RETRO390033 | $92,138 | $23,467 | $23,034 | $23,034 | 3 |
| 550019099 | VALVE HRT SAPIEN23MM RETRO390033 | $92,138 | $23,467 | $23,034 | $79,238 | 14 |
| 573107128 | LEUPROLIDE ACETATE DEPOT 45MG | $90,128 | $22,955 | $45,064 | $45,064 | 3 |
| 573107128 | LEUPROLIDE ACETATE DEPOT 45MG | $90,128 | $22,955 | $25,236 | $77,510 | 14 |
| 550030298 | VALVE HEART SAPIEN 3 20MM 500403 | $87,750 | $22,350 | $21,938 | $21,938 | 3 |
| 550030298 | VALVE HEART SAPIEN 3 20MM 500403 | $87,750 | $22,350 | $21,938 | $75,465 | 14 |
| 550023871 | VALVE CORE 23MM 506174 | $85,050 | $21,662 | $21,263 | $21,263 | 3 |
| 550023871 | VALVE CORE 23MM 506174 | $85,050 | $21,662 | $21,263 | $73,143 | 14 |
| 573108228 | DOSTARLIMAB-GXLY 500MG/10ML INJ | $84,972 | $21,642 | $42,486 | $42,486 | 3 |
| 573108228 | DOSTARLIMAB-GXLY 500MG/10ML INJ | $84,972 | $21,642 | $23,792 | $73,076 | 14 |
| 550024810 | VALVE CORE 31MM TRIAL 441880 | $81,000 | $20,631 | $20,250 | $20,250 | 3 |
| 550024810 | VALVE CORE 31MM TRIAL 441880 | $81,000 | $20,631 | $20,250 | $69,660 | 14 |
| 573104886 | ATEZOLIZUMAB 1200 MG/20 ML | $80,276 | $20,446 | $40,138 | $40,138 | 3 |
| 573104886 | ATEZOLIZUMAB 1200 MG/20 ML | $80,276 | $20,446 | $22,477 | $69,037 | 14 |
| 573104927 | HEMIN INJECTION 350MG | $78,589 | $20,017 | $39,294 | $39,294 | 3 |
| 573104927 | HEMIN INJECTION 350MG | $78,589 | $20,017 | $22,005 | $67,586 | 14 |
| 550023184 | AOR ILIAC GRFT 7MMX12.5CM 367896 | $76,000 | $19,357 | $19,000 | $19,000 | 3 |
| 550023184 | AOR ILIAC GRFT 7MMX12.5CM 367896 | $76,000 | $19,357 | $19,000 | $65,360 | 14 |
| 573107029 | CEMIPLIMAB-RWLC 350MG INJ VIAL | $75,674 | $19,274 | $37,837 | $37,837 | 3 |
| 573107029 | CEMIPLIMAB-RWLC 350MG INJ VIAL | $75,674 | $19,274 | $21,189 | $65,079 | 14 |
Showing top 50 of 17,427 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.